SANOFI (SAN.PA) Fundamental Analysis & Valuation

EPA:SAN • FR0000120578

76.25 EUR
-0.06 (-0.08%)
Last: Mar 11, 2026, 07:00 PM

This SAN.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

5

Overall SAN gets a fundamental rating of 5 out of 10. We evaluated SAN against 54 industry peers in the Pharmaceuticals industry. Both the profitability and the financial health of SAN get a neutral evaluation. Nothing too spectacular is happening here. SAN has a decent growth rate and is not valued too expensively. Finally SAN also has an excellent dividend rating. With these ratings, SAN could be worth investigating further for dividend investing!.


Dividend Valuation Growth Profitability Health

6

1. SAN.PA Profitability Analysis

1.1 Basic Checks

  • SAN had positive earnings in the past year.
  • SAN had a positive operating cash flow in the past year.
  • SAN had positive earnings in each of the past 5 years.
  • Each year in the past 5 years SAN had a positive operating cash flow.
SAN.PA Yearly Net Income VS EBIT VS OCF VS FCFSAN.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

1.2 Ratios

  • With a decent Return On Assets value of 9.85%, SAN is doing good in the industry, outperforming 68.52% of the companies in the same industry.
  • SAN's Return On Equity of 17.49% is in line compared to the rest of the industry. SAN outperforms 59.26% of its industry peers.
  • SAN's Return On Invested Capital of 13.76% is fine compared to the rest of the industry. SAN outperforms 62.96% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for SAN is significantly below the industry average of 14.78%.
  • The 3 year average ROIC (7.41%) for SAN is below the current ROIC(13.76%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 9.85%
ROE 17.49%
ROIC 13.76%
ROA(3y)4.87%
ROA(5y)5.28%
ROE(3y)8.47%
ROE(5y)9.13%
ROIC(3y)7.41%
ROIC(5y)7.45%
SAN.PA Yearly ROA, ROE, ROICSAN.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • The Profit Margin of SAN (17.71%) is better than 70.37% of its industry peers.
  • In the last couple of years the Profit Margin of SAN has declined.
  • SAN has a Operating Margin (23.28%) which is comparable to the rest of the industry.
  • In the last couple of years the Operating Margin of SAN has grown nicely.
  • With a Gross Margin value of 72.55%, SAN perfoms like the industry average, outperforming 53.70% of the companies in the same industry.
  • In the last couple of years the Gross Margin of SAN has remained more or less at the same level.
Industry RankSector Rank
OM 23.28%
PM (TTM) 17.71%
GM 72.55%
OM growth 3Y-0.84%
OM growth 5Y1.78%
PM growth 3Y-3.21%
PM growth 5Y-12.66%
GM growth 3Y1.06%
GM growth 5Y1.33%
SAN.PA Yearly Profit, Operating, Gross MarginsSAN.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

5

2. SAN.PA Health Analysis

2.1 Basic Checks

  • SAN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • SAN has less shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, SAN has less shares outstanding
  • SAN has a worse debt/assets ratio than last year.
SAN.PA Yearly Shares OutstandingSAN.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
SAN.PA Yearly Total Debt VS Total AssetsSAN.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B 100B

2.2 Solvency

  • SAN has a debt to FCF ratio of 1.86. This is a very positive value and a sign of high solvency as it would only need 1.86 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 1.86, SAN belongs to the top of the industry, outperforming 81.48% of the companies in the same industry.
  • SAN has a Debt/Equity ratio of 0.22. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of SAN (0.22) is better than 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF 1.86
Altman-Z N/A
ROIC/WACC1.73
WACC7.94%
SAN.PA Yearly LT Debt VS Equity VS FCFSAN.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B

2.3 Liquidity

  • A Current Ratio of 1.09 indicates that SAN should not have too much problems paying its short term obligations.
  • SAN has a Current ratio of 1.09. This is in the lower half of the industry: SAN underperforms 74.07% of its industry peers.
  • A Quick Ratio of 1.09 indicates that SAN should not have too much problems paying its short term obligations.
  • The Quick ratio of SAN (1.09) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.09
Quick Ratio 1.09
SAN.PA Yearly Current Assets VS Current LiabilitesSAN.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

4

3. SAN.PA Growth Analysis

3.1 Past

  • The Earnings Per Share has been growing slightly by 1.82% over the past year.
  • Measured over the past 5 years, SAN shows a small growth in Earnings Per Share. The EPS has been growing by 5.58% on average per year.
  • The Revenue has been growing slightly by 5.29% in the past year.
  • The Revenue has been growing slightly by 4.57% on average over the past years.
EPS 1Y (TTM)1.82%
EPS 3Y-1.77%
EPS 5Y5.58%
EPS Q2Q%16.79%
Revenue 1Y (TTM)5.29%
Revenue growth 3Y0.97%
Revenue growth 5Y4.57%
Sales Q2Q%7%

3.2 Future

  • Based on estimates for the next years, SAN will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.49% on average per year.
  • The Revenue is expected to grow by 5.29% on average over the next years.
EPS Next Y8.41%
EPS Next 2Y6.95%
EPS Next 3Y8.43%
EPS Next 5Y8.49%
Revenue Next Year6.58%
Revenue Next 2Y6.19%
Revenue Next 3Y5.8%
Revenue Next 5Y5.29%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
SAN.PA Yearly Revenue VS EstimatesSAN.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10B 20B 30B 40B 50B
SAN.PA Yearly EPS VS EstimatesSAN.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8 10

6

4. SAN.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 9.75, the valuation of SAN can be described as very reasonable.
  • SAN's Price/Earnings ratio is rather cheap when compared to the industry. SAN is cheaper than 85.19% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 26.15, SAN is valued rather cheaply.
  • A Price/Forward Earnings ratio of 8.99 indicates a reasonable valuation of SAN.
  • Based on the Price/Forward Earnings ratio, SAN is valued cheaper than 88.89% of the companies in the same industry.
  • SAN's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 24.27.
Industry RankSector Rank
PE 9.75
Fwd PE 8.99
SAN.PA Price Earnings VS Forward Price EarningsSAN.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of SAN indicates a somewhat cheap valuation: SAN is cheaper than 70.37% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 16.87
EV/EBITDA N/A
SAN.PA Per share dataSAN.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • SAN has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.16
PEG (5Y)1.75
EPS Next 2Y6.95%
EPS Next 3Y8.43%

7

5. SAN.PA Dividend Analysis

5.1 Amount

  • SAN has a Yearly Dividend Yield of 5.30%, which is a nice return.
  • Compared to an average industry Dividend Yield of 1.91, SAN pays a better dividend. On top of this SAN pays more dividend than 88.89% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, SAN pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.3%

5.2 History

  • The dividend of SAN has a limited annual growth rate of 4.30%.
Dividend Growth(5Y)4.3%
Div Incr Years6
Div Non Decr Years6
SAN.PA Yearly Dividends per shareSAN.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

  • SAN's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DPN/A
EPS Next 2Y6.95%
EPS Next 3Y8.43%
SAN.PA Yearly Income VS Free CF VS DividendSAN.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

SAN.PA Fundamentals: All Metrics, Ratios and Statistics

SANOFI

EPA:SAN (3/11/2026, 7:00:00 PM)

76.25

-0.06 (-0.08%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)01-29
Earnings (Next)04-23
Inst Owners46.23%
Inst Owner ChangeN/A
Ins Owners0.02%
Ins Owner ChangeN/A
Market Cap184.17B
Revenue(TTM)70.49B
Net Income(TTM)12.49B
Analysts76
Price Target98.37 (29.01%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.3%
Yearly Dividend3.79
Dividend Growth(5Y)4.3%
DPN/A
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)5.22%
Min EPS beat(2)4.58%
Max EPS beat(2)5.86%
EPS beat(4)3
Avg EPS beat(4)3.54%
Min EPS beat(4)-2.29%
Max EPS beat(4)6.02%
EPS beat(8)6
Avg EPS beat(8)4.07%
EPS beat(12)8
Avg EPS beat(12)3.12%
EPS beat(16)11
Avg EPS beat(16)3.47%
Revenue beat(2)0
Avg Revenue beat(2)-1.69%
Min Revenue beat(2)-2.08%
Max Revenue beat(2)-1.3%
Revenue beat(4)0
Avg Revenue beat(4)-1.33%
Min Revenue beat(4)-2.08%
Max Revenue beat(4)-0.63%
Revenue beat(8)2
Avg Revenue beat(8)-0.61%
Revenue beat(12)3
Avg Revenue beat(12)-0.93%
Revenue beat(16)7
Avg Revenue beat(16)14.42%
PT rev (1m)-1.76%
PT rev (3m)-8.6%
EPS NQ rev (1m)0.05%
EPS NQ rev (3m)5.74%
EPS NY rev (1m)0.29%
EPS NY rev (3m)-1.32%
Revenue NQ rev (1m)-0.6%
Revenue NQ rev (3m)-1.7%
Revenue NY rev (1m)0.31%
Revenue NY rev (3m)-0.4%
Valuation
Industry RankSector Rank
PE 9.75
Fwd PE 8.99
P/S 2.61
P/FCF 16.87
P/OCF 16.87
P/B 2.58
P/tB 48.27
EV/EBITDA N/A
EPS(TTM)7.82
EY10.26%
EPS(NY)8.48
Fwd EY11.12%
FCF(TTM)4.52
FCFY5.93%
OCF(TTM)4.52
OCFY5.93%
SpS29.19
BVpS29.55
TBVpS1.58
PEG (NY)1.16
PEG (5Y)1.75
Graham Number72.11
Profitability
Industry RankSector Rank
ROA 9.85%
ROE 17.49%
ROCE 16.67%
ROIC 13.76%
ROICexc 14.92%
ROICexgc 58.3%
OM 23.28%
PM (TTM) 17.71%
GM 72.55%
FCFM 15.49%
ROA(3y)4.87%
ROA(5y)5.28%
ROE(3y)8.47%
ROE(5y)9.13%
ROIC(3y)7.41%
ROIC(5y)7.45%
ROICexc(3y)8.06%
ROICexc(5y)8.26%
ROICexgc(3y)31.82%
ROICexgc(5y)35.77%
ROCE(3y)8.99%
ROCE(5y)9.04%
ROICexgc growth 3Y-8.07%
ROICexgc growth 5Y1.04%
ROICexc growth 3Y-0.36%
ROICexc growth 5Y3.93%
OM growth 3Y-0.84%
OM growth 5Y1.78%
PM growth 3Y-3.21%
PM growth 5Y-12.66%
GM growth 3Y1.06%
GM growth 5Y1.33%
F-Score5
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF 1.86
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion N/A
Profit Quality 87.43%
Current Ratio 1.09
Quick Ratio 1.09
Altman-Z N/A
F-Score5
WACC7.94%
ROIC/WACC1.73
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)127.25%
Profit Quality(5y)123.49%
High Growth Momentum
Growth
EPS 1Y (TTM)1.82%
EPS 3Y-1.77%
EPS 5Y5.58%
EPS Q2Q%16.79%
EPS Next Y8.41%
EPS Next 2Y6.95%
EPS Next 3Y8.43%
EPS Next 5Y8.49%
Revenue 1Y (TTM)5.29%
Revenue growth 3Y0.97%
Revenue growth 5Y4.57%
Sales Q2Q%7%
Revenue Next Year6.58%
Revenue Next 2Y6.19%
Revenue Next 3Y5.8%
Revenue Next 5Y5.29%
EBIT growth 1Y7.73%
EBIT growth 3Y0.11%
EBIT growth 5Y6.43%
EBIT Next Year28.69%
EBIT Next 3Y14.49%
EBIT Next 5Y9.74%
FCF growth 1Y85.47%
FCF growth 3Y9.46%
FCF growth 5Y15.4%
OCF growth 1Y20.22%
OCF growth 3Y1.22%
OCF growth 5Y8.03%

SANOFI / SAN.PA FAQ

Can you provide the ChartMill fundamental rating for SANOFI?

ChartMill assigns a fundamental rating of 5 / 10 to SAN.PA.


Can you provide the valuation status for SANOFI?

ChartMill assigns a valuation rating of 6 / 10 to SANOFI (SAN.PA). This can be considered as Fairly Valued.


Can you provide the profitability details for SANOFI?

SANOFI (SAN.PA) has a profitability rating of 6 / 10.


What is the valuation of SANOFI based on its PE and PB ratios?

The Price/Earnings (PE) ratio for SANOFI (SAN.PA) is 9.75 and the Price/Book (PB) ratio is 2.58.


How financially healthy is SANOFI?

The financial health rating of SANOFI (SAN.PA) is 5 / 10.